U.S.-Ukraine Partnership to Reduce Biological Threats

U.S Embassy in Ukraine, April 22, 2020

The U.S. Embassy would like to set the record straight regarding disinformation spreading in some circles in Ukraine that mirrors Russian disinformation regarding the strong U.S.-Ukrainian partnership to reduce biological threats.

Here in Ukraine, the U.S. Department of Defense’s Biological Threat Reduction Program works with the Ukrainian Government to consolidate and secure pathogens and toxins of security concern in Ukrainian government facilities, while allowing for peaceful research and vaccine development.  We also work with our Ukrainian partners to ensure Ukraine can detect and report outbreaks caused by dangerous pathogens before they pose security or stability threats.

Our joint efforts help to ensure that dangerous pathogens do not fall into the wrong hands.  We’re proud to partner with the Ministry of Health, State Service of Ukraine for Food Safety and Consumer Protection, National Academy of Agrarian Sciences, and the Ministry of Defense to make us all safer.

Anyone can learn more about these efforts on the U.S. Embassy website, at https://ua.usembassy.gov/embassy/kyiv/sections-offices/defense-threat-reduction-office/biological-threat-reduction-program/.

Meanwhile, the Science and Technology Center in Ukraine (STCU), an intergovernmental organization, was established by international agreement in October 1993.  The current Parties to the STCU are Azerbaijan, the European Union, Georgia, Moldova, Ukraine, the United States, and Uzbekistan.

The STCU seeks to advance global peace and prosperity through cooperative Chemical, Biological, Radiological, and Nuclear (CBRN) risk mitigation by supporting civilian science and technology partnerships and collaboration that address global security threats and advance non-proliferation.

More information about the STCU and its programs and projects can be found at http://www.stcu.int.

https://ua.usembassy.gov/u-s-ukraine-partnership-to-reduce-biological-threats/

Start the Conversation

Your email address will not be published.


*